RE-PERG in early-onset Alzheimer's disease: A double-blind, electrophysiological pilot study.
Alberto MavilioDario SistoFlorenza PreteViviana GuadalupiRosanna DammaccoGiovanni AlessioPublished in: PloS one (2020)
RE-PERG is altered in early-stage AD, showing a reduced amplitude with high intrinsic phase variability. It also allows the discrimination of AD from VD. A high intrinsic variability in the PERG signal, determined using RE-PERG, may thus be a new promising test for neurodegenerative diseases.